Primary Tumor Resection With EGFR TKI for Stage IV NSCLC
Clinical trial NCT05215548 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05215548
- Sponsor
- National Taiwan University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2026-10-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.